TrialProceedings of the National Academy of Sciences of the United States of America2012

Immunoglobulin-like transcript receptors on human dermal CD14+ dendritic cells act as a CD8-antagonist to control cytotoxic T cell priming.

Jacques Banchereau et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.